The Role of Opioid Treatment Programs in Hepatitis C Care: A Path to Elimination

The Role of Opioid Treatment Programs in Hepatitis C Care: A Path to Elimination

Between 2010 and 2022 (the latest year for which data are available), 194,375 New Yorkers were diagnosed with hepatitis C (HCV) and of those, 53% (103,213 individuals) are known to have cleared their infection either through treatment or spontaneously. This statistic is worth celebrating, but also highlights the ongoing need for action – the goal outlined in New York State’s Hepatitis C Elimination Plan is to reach 80% by 2030. Furthermore, people who inject drugs are disproportionally affected by HCV – in 2022, 48% of newly reported cases of acute HCV in New York indicated injection drug use as a risk factor. And, when analyzing cases with known risk factors, that figure rose to 81% of newly reported acute cases indicating injection drug use. Providing HCV treatment in opioid treatment program (OTP)s is an innovative and necessary strategy to curb the ongoing epidemic and achieve statewide goals for elimination.

This episode features Abigail Hunter, MPH, MSN, FNP-BC, sharing her experience providing HCV treatment at an OTP and recommendations for listeners interested in integrating treatment into clinical services. Related Content:

Episoder(58)

The Case for Chronic Pain Management among People Who Use Opioids

The Case for Chronic Pain Management among People Who Use Opioids

Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent policy changes and how updated guidelines can...

10 Okt 202446min

An Exciting New Twice-yearly Option for HIV PrEP

An Exciting New Twice-yearly Option for HIV PrEP

“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If a...

10 Sep 202413min

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

Providers calling into our CEI hotline often ask me what to do when their patient's HIV test results are unclear. These ambiguous or discordant test results can be a source of anxiety and confusion fo...

8 Aug 202429min

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

“Nobody goes into adolescent medicine or into a field of medicine that serves adolescent patients because it’s simple and straightforward, right?” In May 2024, the New York State Department of Health ...

11 Jul 202422min

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

13 Jun 202434min

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

6 Jun 202430min

Special Conversations with CEI: The Impact of Hepatitis C Screening during Pregnancy: A Client’s Story

Special Conversations with CEI: The Impact of Hepatitis C Screening during Pregnancy: A Client’s Story

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

30 Mai 202436min

Would you consider Injectable ART for those unable to suppress with oral HIV treatment?

Would you consider Injectable ART for those unable to suppress with oral HIV treatment?

In this episode, Dr. Steven Fine discusses some of the latest data that might be used to support starting patients who are unable to take oral antiretroviral medications on long acting, injectable ARV...

7 Mai 202414min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
foreldreradet
jakt-og-fiskepodden
merry-quizmas
dopet
rss-sunn-okonomi
rss-strid-de-norske-borgerkrigene
hverdagspsyken
podme-bio-3
gravid-uke-for-uke
rss-kull
sovnlos
sinnsyn
tomprat-med-gunnar-tjomlid
dypdykk
rss-var-forste-kaffe
fryktlos